ConductScience.org, home

Paper17530719

Reduced expression of decay-accelerating factor 1 on CD4+ T cells in murine systemic autoimmune disease.

Cauvi DM and 2 others. Arthritis Rheum, 2007. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Reduced expression of decay-accelerating factor 1 on CD4+ T cells in murine systemic autoimmune disease. Papers, record 17530719. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17530719

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reduced expression of decay-accelerating factor 1 on CD4+ T cells in murine systemic autoimmune disease.
PubMed
Journal
Arthritis Rheum
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.38
iCite
Revised in PubMed
2017-11-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cauvi DMDavid M
2Cauvi GGabrielle
3Pollard KMK Michael

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Autoimmune DiseasesMajor topic
CD4-Positive T-LymphocytesMajor topic
CD55 AntigensMajor topic
Gene Expression RegulationMajor topic
Animals
Autoimmunity
B-Lymphocytes
Hyaluronan Receptors
Interleukin-4
Mercury
Mice
Mice, Inbred BALB C
Mice, Inbred DBA
Mice, Inbred NZB
Mice, Knockout
RNA, Messenger

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 ES007511NIEHS NIH HHSUnited StatesR01ES007511PubMed and NIH
ES-07511NIEHS NIH HHSUnited StatesR01ES007511PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
40570142The complement regulator CD55 modulates TLR9 signaling and supports survival in marginal zone B cells.J Immunol2025https://conductscience.org/library/papers/40570142PubMed
40502004Effect of Age on Xenobiotic-Induced Autoimmunity.bioRxiv2025https://conductscience.org/library/papers/40502004PubMed
30742953Mercury-induced inflammation and autoimmunity.Biochim Biophys Acta Gen Subj2019https://conductscience.org/library/papers/30742953PubMed
29055005Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.J Immunol2017https://conductscience.org/library/papers/29055005PubMed
28453771From the Cover: Interplay Between IFN-γ and IL-6 Impacts the Inflammatory Response and Expression of Interferon-Regulated Genes in Environmental-Induced Autoimmunity.Toxicol Sci2017https://conductscience.org/library/papers/28453771PubMed
24818014A tandem repeat in decay accelerating factor 1 is associated with severity of murine mercury-induced autoimmunity.Autoimmune Dis2014https://conductscience.org/library/papers/24818014PubMed
24592327The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease.Autoimmune Dis2014https://conductscience.org/library/papers/24592327PubMed
22578563Definition of IFN-γ-related pathways critical for chemically-induced systemic autoimmunity.J Autoimmun2012https://conductscience.org/library/papers/22578563PubMed
22136142Depletion of complement does not impact initiation of xenobiotic-induced autoimmune disease.Immunology2012https://conductscience.org/library/papers/22136142PubMed
21793797β2-microglobulin is required for the full expression of xenobiotic-induced systemic autoimmunity.J Immunotoxicol2011https://conductscience.org/library/papers/21793797PubMed
20408894Decay-accelerating factor 1 (Daf1) deficiency exacerbates xenobiotic-induced autoimmunity.Immunology2010https://conductscience.org/library/papers/20408894PubMed
20078109Toxicology of autoimmune diseases.Chem Res Toxicol2010https://conductscience.org/library/papers/20078109PubMed
17947652Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production.J Immunol2007https://conductscience.org/library/papers/17947652PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17530719

GET https://conductscience.org/api/papers/v1/17530719/authors